Technology
Health
Biotechnology

Unity Biotechnology

$8.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.43 (5.35%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell UBX and other stocks, options, ETFs, and crypto commission-free!

About

Unity Biotechnology, Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel David, Jan van Deursen, Judith Campisi and Daohong Zhou in March 2009 and is headquartered in Brisbane, CA.

Employees
106
Headquarters
Brisbane, California
Founded
2009
Market Cap
363.26M
Price-Earnings Ratio
β€”
Dividend Yield
β€”
Average Volume
184.45K
High Today
$8.58
Low Today
$8.13
Open Price
$8.13
Volume
72.47K
52 Week High
$24.56
52 Week Low
$7.39

Collections

Technology
Health
Biotechnology
Research And Development
Therapy
2018 IPO
US
North America

News

Associated PressMay 8

UNITY Biotechnology, Inc. Reports First Quarter 2019 Financial Results

SAN FRANCISCO, May 08, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (β€œUNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today reported first quarter 2019 financial results. UNITY also announced the last study visit for the last subject enrolled in the Phase 1 study of UBX0101 in patients with osteoarthritis of the knee occurred in April 2019. UNITY remains on track to report initial study results in the secon...

287

Earnings

-$4.69
-$3.27
-$1.85
-$0.43
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.51 per share
Actual
-$0.44 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.